# Heed The Warning: A Case Report on Capsular Warning Syndrome

## TL;DR

This case report describes a rare neurological condition called capsular warning syndrome and emphasizes the need for close monitoring even when symptoms appear to resolve.

## Contribution

The paper highlights the importance of recognizing capsular warning syndrome in emergency medicine and its implications for patient management.

## Key findings

- The patient experienced recurrent neurological symptoms consistent with capsular warning syndrome.
- Capsular warning syndrome is associated with a high risk of stroke within the first 48 hours.
- Thrombolysis remains a primary treatment, but its effectiveness in this condition is still under investigation.

## Abstract

Evaluating patients with acute neurologic deficits is a regular occurrence in the emergency department (ED), but some presentations warrant increased concern. This case highlights the importance of repeat evaluations and how resolution of symptoms does not rule out a more ominous underlying pathology.

A 59-year-old male with a past medical history of coronary artery disease and Human immunodeficiency viruses (HIV) presented to a Level II trauma and comprehensive stroke center for left-sided facial droop and left-sided hemiparesis. Computed tomography of the brain including angiography and perfusion was performed revealing no hemorrhage or large vessel occlusion. Given his National Institutes of Health Stroke Scale score of 11, he received alteplase and subsequently experienced several episodes of resolution and recurrence of his symptoms while in the ED. Magnetic resonance imaging revealed an acute ischemic infarct in the right basal ganglia and insular region, which along with his clinical presentation was consistent with capsular warning syndrome.

Capsular warning syndrome is a rare clinical entity with an incidence ranging from 1.5–5% in stroke patients. Its recognition is crucial when making decisions concerning management, as resolution of symptoms should still garner a high level of attention given that the the increased risk of stroke with permanent neurological disability is highest within the first 48 hours. The role of thrombolysis continues to be an area of focus as its benefit has not yet been determined but continues to be the mainstay therapy in the correct clinical setting. This is especially true in the cases of recurrent episodes post thrombolysis, which does not preclude the diagnosis of capsular warning syndrome but should heighten the need for acute management of these patients and close monitoring. This case illustrates its unique presentation and the need for increased recognition and understanding within the field of emergency medicine.